Wiskott-Aldrich Syndrome
Showing 1 - 25 of >10,000
Wiskott-Aldrich Syndrome Trial in Atlanta, Milan (OTL-103)
Active, not recruiting
- Wiskott-Aldrich Syndrome
- OTL-103
-
Atlanta, Georgia
- +1 more
Sep 27, 2022
Primary Immunodeficiency Diseases
Active, not recruiting
- Wiskott- Aldrich Syndrome
- ADA Deficient SCID
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Wiskott-Aldrich Syndrome (WAS) Trial in Milan (OTL-103)
Active, not recruiting
- Wiskott-Aldrich Syndrome (WAS)
- OTL-103
-
Milan, ItalyOspedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Apr 21, 2022
Participation in a Research Registry for Immune Disorders
Recruiting
- Primary Immunodeficiencies
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant
Recruiting
- Immune Deficiency Disorders
- +13 more
- Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
-
Saint Louis, MissouriWashington University
Apr 25, 2022
Wiskott-Aldrich Syndrome Trial in London (Autologous CD34 positive cells transduced with a lentiviral vector containing human
Completed
- Wiskott-Aldrich Syndrome
- Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene
-
London, United Kingdom
- +1 more
May 31, 2021
Wiskott-Aldrich Syndrome Trial in Paris, London (Autologous CD34+ cells transduced with WASP lentiviral vector)
Active, not recruiting
- Wiskott-Aldrich Syndrome
- Autologous CD34+ cells transduced with WASP lentiviral vector
-
Paris, France
- +1 more
May 31, 2021
Severe Combined Immunodeficiency (SCID), Immunodeficiency With Predominant T-cell Defect, Unspecified, Severe Chronic
Enrolling by invitation
- Severe Combined Immunodeficiency (SCID)
- +8 more
- CD3/CD19 negative allogeneic hematopoietic stem cells
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
Dec 6, 2021
Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.
Completed
- Wiskott-Aldrich Syndrome
-
Moscow, Russian FederationDmitry Rogachev National Research Center of Pediatric Hematology
Dec 24, 2020
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 23, 2023
Bone Marrow Failure Syndrome, Thalassemia, Sickle Cell Disease Trial in Gainesville (Thiotepa--single daily dose,
Recruiting
- Bone Marrow Failure Syndrome
- +15 more
- Thiotepa--single daily dose
- Thiotepa--escalated dose
-
Gainesville, FloridaUF Health Shands Children's Hospital
Jul 8, 2021
Wiskott-Aldrich Syndrome Trial in Moscow (Romiplostim, Eltrombopag)
Recruiting
- Wiskott-Aldrich Syndrome
-
Moscow, Russian FederationDmitry Rogachev National Research Center of Pediatric Hematology
May 4, 2020
Baby Detect : Genomic Newborn Screening
Recruiting
- Congenital Adrenal Hyperplasia
- +126 more
-
Liege, Wallonia, BelgiumCRMN, Hôpital La Citadelle
Jan 24, 2023
Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990
Completed
- Wiskott-Aldrich Syndrome
-
Birmingham, Alabama
- +42 more
Aug 6, 2020
Skin Microbes in Healthy People and in People With Skin
Recruiting
- Atopic Dermatitis
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Hurler Syndrome, Fanconi Anemia, Glanzmann Thrombasthenia Trial in Atlanta (Abatacept)
Completed
- Hurler Syndrome
- +14 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Dec 20, 2019
Wiskott-Aldrich Syndrome, Thrombocytopenia, Bleeding Trial in New York (Promacta, blood drawing in patients with WAS, blood
Terminated
- Wiskott-Aldrich Syndrome
- +2 more
- Promacta
- +2 more
-
New York, New YorkWeill Cornell Medical College
Mar 15, 2019
Subject Interviews in Wiskott-Aldrich Syndrome (WAS)
Completed
- Wiskott-Aldrich Syndrome
- Patient Interview guide
- +4 more
-
Collegeville, PennsylvaniaGSK Investigational Site
Mar 13, 2019
Wiskott-Aldrich Syndrome, Hematopoietic Stem Cell Transplantation, Graft Failure Trial in Moscow (G-CSF for Conditioning before
Unknown status
- Wiskott-Aldrich Syndrome
- +2 more
- G-CSF for Conditioning before HSCT.
- Plerixafor for Conditioning before HSCT.
-
Moscow, Russian FederationDmitry Rogachev Federal Research and Clinical Centre of Paediatr
Dec 10, 2018
Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS
Recruiting
- Immunodeficiencies
- Immune Dysregulation Syndromes
- Apha/beta T and CD19+ cell depletion using CliniMACS device
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 8, 2022
Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Recruiting
- Primary Immunodeficiency (PID)
- +4 more
- data collection
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Feb 9, 2022
Wiskott-Aldrich Syndrome Trial in Paris (Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS
Completed
- Wiskott-Aldrich Syndrome
- Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene
-
Paris, FranceHôpital Necker-Enfants Malades
May 18, 2018
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +77 more
- fludarabine phosphate
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 16, 2019
Staphylococcus Aureus, Atopic Dermatitis Trial (Natural Lactic Acid-enriched Cream)
Not yet recruiting
- Staphylococcus Aureus
- Atopic Dermatitis
- Natural Lactic Acid-enriched Cream
- (no location specified)
Oct 13, 2021